Market Overview

UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Brunswick Corporation

Share:
Related BC
Benzinga's Top Upgrades
Benzinga's Top Initiations
Beyond The Biotech Space - Brunswick Corp NYSE BC (Marketfy Insights)

In a report published Monday, BMO Capital Markets reiterated its Market Perform rating on Brunswick Corporation (NYSE: BC), and raised its price target from $23.00 to $25.00.

BMO Capital noted, “BC reported 3Q12 EPS of $0.43, excluding one-time items. This was ahead of our expectation of $0.37 and well ahead of the Street's expectation for $0.29. The company reported EPS of $0.33 excluding one-time items in the year-ago period. While earnings exceeded our estimate, the outperformance came from gross margin improvement, with sales underperforming our expectations. We believe the company's strong execution in a sluggish boat market is encouraging, and helped the stock recoup some recent losses in the market. However, we still believe macro risk and industry uncertainty still outweigh the company's good near-term execution.”

Brunswick Corporation closed on Friday at $23.05.

Latest Ratings for BC

DateFirmActionFromTo
Jul 2015RBC CapitalUpgradesSector PerformOutperform
Jun 2015Sterne Agee - CRTInitiates Coverage onBuy
May 2015CitigroupMaintainsBuy

View More Analyst Ratings for BC
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings

 

Related Articles (BC)

Get Benzinga's Newsletters